89 related articles for article (PubMed ID: 25992486)
1. Two polymorphisms in the Cx40 promoter are associated with hypertension and left ventricular hypertrophy preferentially in men.
Schmidt K; Kaiser FJ; Erdmann J; Wit Cd
Clin Exp Hypertens; 2015; 37(7):580-6. PubMed ID: 25992486
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men.
Firouzi M; Kok B; Spiering W; Busjahn A; Bezzina CR; Ruijter JM; Koeleman BP; Schipper M; Groenewegen WA; Jongsma HJ; de Leeuw PW
J Hypertens; 2006 Feb; 24(2):325-30. PubMed ID: 16508580
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension.
Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R
Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826
[TBL] [Abstract][Full Text] [Related]
4. A novel GJA5 variant associated with increased risk of essential hypertension.
Wang J; Wang XC; Gu ZH; Ren GW; Zhao XH; Qu XK; Xu YJ; Yang YQ
Am J Transl Res; 2023; 15(2):1259-1270. PubMed ID: 36915790
[TBL] [Abstract][Full Text] [Related]
5. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation.
Wirka RC; Gore S; Van Wagoner DR; Arking DE; Lubitz SA; Lunetta KL; Benjamin EJ; Alonso A; Ellinor PT; Barnard J; Chung MK; Smith JD
Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):87-93. PubMed ID: 21076161
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between connexin40 polymorphisms and coronary artery disease.
Pfenniger A; van der Laan SW; Foglia B; Dunoyer-Geindre S; Haefliger JA; Winnik S; Mach F; Pasterkamp G; James RW; Kwak BR
Atherosclerosis; 2012 May; 222(1):148-53. PubMed ID: 22405441
[TBL] [Abstract][Full Text] [Related]
7. Restoration of connexin 40 (Cx40) in Renin-producing cells reduces the hypertension of Cx40 null mice.
Le Gal L; Alonso F; Wagner C; Germain S; Nardelli Haefliger D; Meda P; Haefliger JA
Hypertension; 2014 Jun; 63(6):1198-204. PubMed ID: 24614215
[TBL] [Abstract][Full Text] [Related]
8. The gene polymorphism of LOX1 predicts the incidence of LVH in patients with essential hypertension.
Xu X; Hou X; Liang Y; Li F; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
Cell Physiol Biochem; 2014; 33(1):88-96. PubMed ID: 24480971
[TBL] [Abstract][Full Text] [Related]
9. The association of human connexin 40 genetic polymorphisms with atrial fibrillation.
Juang JM; Chern YR; Tsai CT; Chiang FT; Lin JL; Hwang JJ; Hsu KL; Tseng CD; Tseng YZ; Lai LP
Int J Cardiol; 2007 Mar; 116(1):107-12. PubMed ID: 16814413
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension.
Robador PA; Moreno MU; Beloqui O; Varo N; Redón J; Fortuño A; Zalba G; Díez J
J Hypertens; 2010 Nov; 28(11):2219-26. PubMed ID: 20683337
[TBL] [Abstract][Full Text] [Related]
11. Variants of tumor necrosis factor-induced protein 3 gene are associated with left ventricular hypertrophy in hypertensive patients.
Xue H; Wang SX; Wang XJ; Xin Y; Wang H; Song XD; Sun K; Wang YB; Hui RT
Chin Med J (Engl); 2011 May; 124(10):1498-503. PubMed ID: 21740805
[TBL] [Abstract][Full Text] [Related]
12. Genetic background of left ventricular hypertrophy in Uzbek hypertensive men.
Kurbanova D; Eliseyeva M
Turk Kardiyol Dern Ars; 2010 Oct; 38(7):466-72. PubMed ID: 21206199
[TBL] [Abstract][Full Text] [Related]
13. Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension.
Jobs A; Schmidt K; Schmidt VJ; Lübkemeier I; van Veen TA; Kurtz A; Willecke K; de Wit C
Hypertension; 2012 Dec; 60(6):1422-9. PubMed ID: 23090768
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy.
Wang S; Fu C; Wang H; Shi Y; Xu X; Chen J; Song X; Sun K; Wang J; Fan X; Wang H; Yang X; Huan T; Hui R
Clin Chem Lab Med; 2007; 45(8):962-7. PubMed ID: 17579564
[TBL] [Abstract][Full Text] [Related]
15. Interplay between connexin40 and nitric oxide signaling during hypertension.
Le Gal L; Alonso F; Mazzolai L; Meda P; Haefliger JA
Hypertension; 2015 Apr; 65(4):910-5. PubMed ID: 25712722
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of connexin-40 gene variants in atrial tissues and blood from atrial fibrillation subjects.
Tchou GD; Wirka RC; Van Wagoner DR; Barnard J; Chung MK; Smith JD
BMC Med Genet; 2012 Nov; 13():102. PubMed ID: 23134779
[TBL] [Abstract][Full Text] [Related]
17. Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease.
Carballo S; Pfenniger A; Carballo D; Garin N; James RW; Mach F; Shah D; Kwak BR
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351227
[TBL] [Abstract][Full Text] [Related]
18. The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients.
Gu GL; Yang QY; Zeng RL; Xu XL
J Transl Med; 2015 Jan; 13():14. PubMed ID: 25591903
[TBL] [Abstract][Full Text] [Related]
19. Novel estrogen receptor alpha promoter polymorphism increases ventricular hypertrophic response to hypertension.
Figtree GA; Kindmark A; Lind L; Grundberg E; Speller B; Robinson BG; Channon KM; Watkins H
J Steroid Biochem Mol Biol; 2007 Feb; 103(2):110-8. PubMed ID: 17095210
[TBL] [Abstract][Full Text] [Related]
20. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
